Adcytherix

Adcendo

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.

Adcendo ApS

The company develops antibody-drug conjugates to treat patients with advanced solid tumors and cancers that have high unmet medical needs.

TORL BioTherapeutics

This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.

Emergence Therapeutics

This biopharmaceutical company develops antibody-drug conjugate immunotherapies to treat solid tumours for patients with high unmet medical needs.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

Ona Therapeutics

This company develops antibody-drug conjugates to treat patients with advanced and metastatic cancers which have become resistant to existing therapies.

Angiex

This company develops antibody-drug conjugates for clinicians and pharmaceutical partners to treat solid cancers and vascular diseases.